1. ALLA AKTIER
  2. NYHETER
  3. ELEKTA

Elekta

Nyheter Elekta Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Invitation to the presentation of Elekta’s first quarter 2022/23

STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2022/23 at 10:00 a.m. CEST on August 25. The interim report for the first quarter will be published at 7:30 a.m. CEST on the same day.

The company’s development will be presented by Elekta’s President and CEO Gustaf Salford together with CFO Tobias Hägglöv. After the presentation, held in English, a Q&A session will follow.
 
The presentation will be broadcasted live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta’s website after the call.
 
Welcome!
 
Time: Thursday, August 25, at 10:00 a.m. CEST
 
Telephone numbers to join phone conference:
UK: +44 207 107 0613
USA: +1 631 570 5613
Sweden: +46 8 5051 0031
 
Webcast:
https://elekta-qreports.creo.se/220825

# # #

For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 7625, e-mail: cecilia.ketels@elekta.com
Time zone: CET (Central European Time)

About Elekta

As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.

Attachments

Invitation to the presentation of Elekta’s first quarter 2022/23

Datum 2022-08-09, kl 10:00
Källa MFN
Bifogade filer
Invitation to the presentation of Elekta’s first quarter 2022/23